Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Chinook Therapeutics Inc (KDNY)

Chinook Therapeutics Inc (KDNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chinook Therapeutics Inc 400 FAIRVIEW AVENUE NORTH SUITE 900 SEATTLE WA 98109 USA

P: 206-485-7051

Description:

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on developing precision medicines for kidney diseases. Chinook Therapeutics, Inc., formerly known as Aduro Biotech Inc., is based in BERKELEY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 1,273,705
Enterprise Value, $K 986,875
Shares Outstanding, K 63,941
Annual Sales, $ 51,630 K
Annual Net Income, $ -102,940 K
Last Quarter Sales, $ 2,500 K
Last Quarter Net Income, $ -55,980 K
60-Month Beta 0.10
% of Insider Shareholders 23.38%
Float, K 48,992
% Float 76.62%
Short Volume Ratio 0.59

Growth:

1-Year Return 21.32%
3-Year Return 234.79%
5-Year Return -58.28%
5-Year Revenue Growth 1.87%
5-Year Earnings Growth 72.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 11/10/22
Next Earnings Date 11/14/22
Earnings Per Share ttm -1.84
EPS Growth vs. Prev Qtr -36.07%
EPS Growth vs. Prev Year -22.06%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 10/02/20

KDNY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.30%
Return-on-Assets % -20.60%
Profit Margin % -199.38
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 26.53
Price/Cash Flow N/A
Price/Book 2.49
Book Value/Share 8.60
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar